Endocrine Therapy of Breast Cancer
Keywords: Bisphosphonates; Breast cancer; Early Breast Cancer Trial-ists' Collaborative Group (EBCTCG); GnRH agonists; Non-steroidal anti-inflammatory drugs (NSAIDs); Osteonecrosis; SERM; Selective estrogen-receptor modulators; adjuvant therapy; adrenalec-tomy; aromatase inhibitors; atypical hyperplasia; carcinogenesis; chemoprevention; clodronate; cyclooxygenase (COX); dual-energy x-ray absorptiometry (DXA); endocrine therapy; estradiol; estrogen-receptor positive tumors; gonadotropin-releasing hormone (GnRH); hypophysectomy; ibandronate; lymph node; ovarian suppres-sive drugs; ovariectomy; postmenopausal osteoporosis; progesterone-receptor; prophylaxis; raloxifene; risedronate; serum estradiol; tamoxifen
Document Type: Research Article
Publication date: 2011-02-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.